Everolimus with reduced calcineurin inhibitor versus mycophenolate with standard calcineurin inhibitor in de novo renal transplantation

Phase 4, randomised, open-label trial in chronic kidney disease (CKD) and kidney transplant immunosuppression comparing Everolimus plus reduced calcineurin inhibitor with Mycophenolate plus standard calcineurin inhibitor (2 arms). Primary endpoint: Primary analysis method. Started Aug 2013; status: completed.